Corrigendum to Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. [Intern Med J, 2014, 44, 903-910] DOI: 10.1111/imj.12516;Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital

Internal Medicine Journal

Volumn 44, Issue 9, 2014, Pages 903-910

  Fanning, Matthew ^a   McKean, M ^b   Seymour, K ^a   Pillans, P ^b   Scott, I ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Antibacterial agent; Chronic obstructive; Guideline adherence; Hospital; Outcomes assessment; Pulmonary disease

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CLAVULANIC ACID; DOXYCYCLINE; FLUCLOXACILLIN; GENTAMICIN; PENICILLIN G; ROXITHROMYCIN; TICARCILLIN; ANTIINFECTIVE AGENT; CORTICOSTEROID;

ABSENCE OF SIDE EFFECTS; AGED; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG COST; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TERTIARY CARE CENTER; DISEASE COURSE; ECONOMICS; HAEMOPHILUS INFECTIONS; HEALTH CARE COST; HOSPITALIZATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PNEUMOCOCCAL INFECTIONS; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA;

ADRENAL CORTEX HORMONES; AGED; ANTI-BACTERIAL AGENTS; AUSTRALIA; DISEASE PROGRESSION; FEMALE; GUIDELINE ADHERENCE; HAEMOPHILUS INFECTIONS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; OXYGEN INHALATION THERAPY; PATIENT READMISSION; PNEUMOCOCCAL INFECTIONS; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TERTIARY CARE CENTERS;

EID: 84912077446     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12614     Document Type: Erratum

References (32)

1. AIHW. Australia's Health 2012. Australia's Health no. 13. Cat. no. AUS 156. Canberra: AIHW; 2012. [cited 2014 May 6] Available from URL: http://www.aihw.gov.au/publication-detail/?id =6442468376
2. Australian Centre for Asthma Monitoring. Asthma in Australia 2011: With a Focus Chapter on Chronic Obstructive Pulmonary Disease. Asthma Series no. 4. Cat. no. ACM 22. Canberra: AIHW; 2011. [cited 2012 Jun 29] Available from URL: http://www.aihw.gov.au/publication-detail/?id=10737420159
3. McKenzie DK, Abramson M, Crockett AJ, Glasgow N, Jenkins S, McDonald C et al. The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Queensland: The Australian Lung Foundation; 2011.
4. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease. (GOLD). 2014; [cited 2014 Jun] Available from URL: http://www.goldcopd.org/
5. Moulds R (ed.). Acute Exacerbation of COPD. eTG Complete [Internet]. Melbourne: Therapeutic Guidelines Limited; 2010 [updated 2010 Nov]. [cited 2012 Feb 28] Available from URL: http://online.tg.org.au/ip/
6. Siddiqi A, Sethi S. Optimizing antibiotic selection in treating COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2008; 3: 31-44.
7. Radford J, CardiffL, Pillans P, Fielding D, Looke D. Drug usage evaluation of antimicrobial therapy for community-acquired pneumonia. Aust J Hosp Pharm 1999; 29: 317-20.
8. Robertson M, Dartnell J, Korman T. Vancomycin and teicoplanin use in Victorian hospitals: the Victorian Drug Usage Evaluation Group. Med J Aust 1999; 171: 127-31.
9. To N, Khan Z, Chiu F, Jordan M, Koller L, Daly G et al. Low levels of adherence to antibiotic prescribing guidelines within emergency departments. Aust J Hosp Pharm 1999; 29: 155-8.
10. Robertson M, Korman T, Dartnell J, Ioannides-Demos L, Kirsa S, Lord J et al. Ceftriaxone and cefotaxime use in Victorian hospitals. Med J Aust 2002; 176: 524-9.
11. Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008; 168: 351-6.
12. Duguid M, Cruickshank M. Antimicrobial Stewardship in Australian Hospitals. Sydney: The Australian Commission on Safety and Quality in Health Care; 2011; 208.
13. Dellit T, Owens R, McGowan J, Gerding D, Weinstein R, Burke J et al. Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
14. Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, et al. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 2006; 34: 2959-66.
15. Dellinger R, Levy M, Carlet J, Bion J, Parker M, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2008; 34: 17-60.
16. Patterson T, Loy L, Pillans P. Princess Alexandra Hospital Prescribing Guidelines, 8th edn. Queensland: Queensland Health; 2011.
17. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003; 56: 221-9.
18. Lodewijckx C, Sermeus W, Vanhaecht K, Panella M, Deneckere S, Leigheb F et al. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. J Eval Clin Pract 2009; 15: 1101-10.
19. Reissig A, Mempel C, Schumacher U, Copetti R, Gross F, Aliberti S. Microbiological diagnosis and antibiotic therapy in patients with community acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines. Lung 2013; 191: 239-46.
20. Roberts C, Lopez-Campos J, Pozo-Rodriguez F, Hartl S. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax 2013; 68: 1169-71.
21. Desai H, Richter S, Doern G, Heilmann K, Dohrn C. Antibiotic resistant in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure. COPD 2010; 7: 337-44.
22. Montero M, Dominguez M, Orozco-Levi M, Salvado M. Clinical and epidemiological study of mortality of COPD patients infected with multi resistant Pseudomonas aeruginosa: a case control study. Infection 2009; 37: 16-19.
23. Andre-Alves M, Jardim JR, Silva R, Fiss E, Noronha D, Teixeira P. Comparison between azithromycin and amoxicillin in the treatment of infectious exacerbation of chronic obstructive pulmonary disease. J Bras Pneumol 2007; 33: 43-50.
24. Hernandez S, Llor C, Ribas A, Alvarez C, Cots JM, Bayona C et al. Efficacy of amoxicillin versus amoxicillin/clavulanate in acute exacerbations of chronic obstructive pulmonary disease in primary care. Int J Chron Obstruct Pulmon Dis 2009; 4: 45-53.
25. Collignon PJ. Intravascular catheter associated sepsis: a common problem. Med J Aust 1994; 161: 374-8.
26. Silber SH, Garrett C, Singh R, Sweeney A, Rosenberg C, Parachiv D et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 2003; 124: 1798-804.
27. Dedier J, Singer DE, Chang Y, Moore M, Atlas S. Processes of care, illness severity, and outcomes in the management of community acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161: 2099-104.
28. Bruns A, Oosterheert J, Hustinx W, Gaillard C, Hak E, Hoepelman A. Time for first antibiotic dose is not predictive for the early clinical failure of moderate severe community acquired pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28: 913-19.
29. Welker J, Huston M, McCue J. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008; 168: 351-6.
30. Kanwar M, Brar N, Khatib R, Fakih M. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007; 131: 1865-9.
31. Moulds R (ed.). Moderate to severe community-acquired pneumonia in adults-inpatient treatment [revised June 2010]. In: eTG complete [Internet]. Melbourne: Therapeutic Guidelines Limited; 2012. [cited 2012 Mar 25] Available from URL: https://online-tg-org-au.cknservices.dotsec.com/ip/
32. Duguid M, Cruickshank M, eds. Antimicrobial Stewardship in Australian Hospitals. Sydney: Australian Commission on Safety and Quality in Health Care; 2011; 65.